𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PL.02.01 CSF biomarkers in Alzheimer's disease – use in clinical diagnosis and to monitor treatment effects

✍ Scribed by K. Blennow

Book ID
118596777
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
42 KB
Volume
20
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Can CSF biomarkers or pre-treatment prog
Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?
✍ Å. K. Wallin; O. Hansson; K. Blennow; E. Londos; L. Minthon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 1 views

## Abstract ## Objective The main objective of this study was to investigate possible predictors of response to cholinesterase inhibitor (ChEI) treatment, including pre‐treatment progression rates and levels of the cerebrospinal fluid (CSF) biomarkers. A secondary objective was to evaluate whether